Welcome to the e-CCO Library!

P535: The use of therapeutic drug monitoring for infliximab and adalimumab in inflammatory bowel disease: Practice patterns, understanding and interpretation
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.A. Samaan*, P.M. Irving

Created: Thursday, 21 February 2019, 9:14 AM
P536 Early prediction of intravenous corticosteroid therapy failure in moderate–severe ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Croft1, A. Lord2, G. Radford-Smith1

Created: Thursday, 30 January 2020, 10:12 AM
P536: Combination therapy of bone marrow mesenchymal stromal cells and azathioprine not affect the clinical course luminal Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Knyazev O.*1, Parfenov A.1, Fadeeva N.1,2, Konoplyannikov A.3, Kagramanova A.1, Ruchkina I.1

Created: Wednesday, 20 February 2019, 10:36 AM
P536: Comparison of outcomes of infliximab biosimilar CT-P13 with infliximab originator in patients with inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Yüksel, I.(1,2);Baspınar, B.(1);Durak, M.B.(1);Kilic, V.(1);Kivrakoglu, F.(1,2);Guven, I.E.(1);Kosar, K.(1);Erdogan, C.(1);Alkan, A.(3);
Created: Friday, 11 February 2022, 3:56 PM
P536: Effectiveness, safety and persistence of treatment with ustekinumab in a cohort of patients with moderate-to-severe refractory Crohn's Disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: Morales Bermúdez, A.I.(1);Bravo Aranda, A.M.(1);Martinez Burgos, M.(1);Olmedo Martín, R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P536: Is there any association between fat body mass and bone mineral density in patients with Inflammatory Bowel Disease?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ratajczak, A.E.(1)*;Michalak, M.(2);Szymczak-Tomczak, A.(1);Rychter, A.M.(1);Zawada, A.(1);Skoracka, K.(1);Dobrowolska, A.(1);Krela-Kaźmierczak, I.(1);
Created: Friday, 14 July 2023, 11:05 AM
P536: Minimally invasive gasless technique for ileocolic resection using an existing McBurney incision
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Fazzolari1, G. Bagaglini1, S. D'Ugo1,2*, B. Sensi1, A. Di Giorgio1, G. Sica1

Created: Thursday, 21 February 2019, 9:14 AM
P536: Thiopurine metabolite levels in pregnant IBD patients and infants following intrauterine thiopurine exposure
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Flanagan*1, A. Ross1, A. L. Hamilton1, S. J. Bell1

Created: Friday, 22 February 2019, 9:41 AM
P537 Real-world long-term effectiveness of ustekinumab in Crohn’s disease: Results from the ENEIDA registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.I. Iborra Colomino1, B. Beltrán1, A. Fernández-Clotet2, E. Iglesias Flores3, P. Navarro4, M. Rivero5, A. Gutiérrez6, M. Sierra-Ausin7, F. Mesonero8, R. Ferreiro-Iglesias9, J. Hinojosa10, X. Calvet11, B. Sicilia12, C. González-Muñoza13, B. Antolín14, M. González Vivo15, A.Y. Carbajo16, S. García17, A. Martín-Cardona18, G. Surís Marín19, M.D. Martín-Arranz20, R. De Francisco21, F. Cañete22, T. Carlos23, F. Gomollón24, R. Lorente25, I. Rodríguez-Lago26, A. Forés-Bosch27, E. Bernardos28, L. Ramos29, P. Delgado30, A. Hernández31, M. Van Domselaar32, D. Hervás33, E. Domènech34, P. Nos1

Created: Thursday, 30 January 2020, 10:12 AM
P537: Adalimumab: Relevance of drug trough levels and antibodies assessment in the prognosis of Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Perdigoto, C. Macedo*, F. Portela, S. Lopes, M. Ferreira, S. Mendes, M. Ferreira, L. Tomé

Created: Thursday, 21 February 2019, 9:14 AM
P537: Anemia in Crohn's Disease: Response to treatment and risk of recurrence
Year: 2021
Source: ECCO'21 Virtual
Authors: Gharbi, G.(1);Bibani, N.(1);Sabbah, M.(1);Nawel, B.(1);Trad, D.(1);Ouakaa, A.(1);Elloumi, H.(1);Gargouri, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P537: Is anti-TNF therapeutic drug monitoring of value in IBD patients in clinical remission?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Subramaniam K.*1,2, Watthayalage R.1, Neeman T.3, Pavli P.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P537: Prevalence of post-COVID-19 vaccination IBD flare-ups: a single-center prospective study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Roblin, X.(1)*;Williet, N.(2);Faure, J.(3);Bastide, L.(2);Barrau, M.(2);Paul, S.(4);
Created: Friday, 14 July 2023, 11:05 AM
P537: Steroid use in patients with immune checkpoint inhibitor colitis
Year: 2022
Source: ECCO'22
Authors: Crothers-Stomps, L.(1);Mohsen, W.(1);Kakkadasam Ramaswamy, P.(1);Mason, R.(2);Dzienis, M.(2);Edwards, J.(1);
Created: Friday, 11 February 2022, 3:56 PM
P537: The impact of early disease control with vedolizumab on surgery rates among patients with Crohn’s disease: a post-hoc analysis of the GEMINI trials
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Dulai*1, L. Peyrin-Biroulet2, K. Hahn3, N. Khalife4, D. Lindner5, K. Lasch6, D. Demuth7, H. Patel8, V. Jairath9

Created: Friday, 22 February 2019, 9:41 AM
P538 Pregnancy outcomes in women with psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis treated with ustekinumab
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Geldhof1, S. Volger2, C.B. Lin2, C. O’Brien2, I. Tikhonov2

Created: Thursday, 30 January 2020, 10:12 AM
P538: Can enteral polymeric diet change the post-surgical outcome in Crohn's disease patients? A pilot study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ceccarelli L.*1, Franceschi M.2, Bertani L.3, Nieri C.2, de Bortoli N.3, Mumolo G.1, Laino G.3, Albano E.3, Tapete G.3, Marchi S.3, Buccianti P.2, Costa F.1

Created: Wednesday, 20 February 2019, 10:36 AM
P538: Enteral nutrition for the maintenance of remission in adults with inactive Crohn’s disease: A meta-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

W. Tang*

Created: Thursday, 21 February 2019, 9:14 AM
P538: Implementation of Kono-S anastomosis as a new standard of surgical care
Year: 2022
Source: ECCO'22
Authors: Adamou, A.(1);Müller, G.(1);Iesalnieks, I.(1);
Created: Friday, 11 February 2022, 3:56 PM
P538: Suboptimal disease control is common in patients with Crohn's perianal fistulas with capacity to optimise medical and surgical treatment in real-world experience: A cross-sectional analysis of baseline disease characteristics in the FINESS study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: De Gregorio, M.(1,2)*;D'Souza, B.(3,4);Connell, W.(1);Kamm, M.A.(1,2);Woods, R.(3);Connor, S.J.(5,6,7);Thompson, A.J.(1,2);Ding, N.S.(1,2);
Created: Friday, 14 July 2023, 11:05 AM